Lateral unicompartmental knee arthroplasty: is really a good option?

Introduction: Lateral unicompartmental knee arthroplasties (LUKA) account for only < 1% of all knee arthroplasties and for only 5–10% of all unicompartmental knee replacements. This means that there is less published literature on these procedures and that the surgeon's experience with them is smaller than with medial UKA. The aim of this study was to analyze the survival and the clinical-functional outcomes of LUKA according to the type of bearing surface (all-polyethylene versus metal-backed) used. Materials and methods: This was a retrospective study including 42 LUKAs operated between 2009 and 2021. Two fixed polyethylene-bearing models were used: the all-polyethylene ACCURIS knee (38%) and the metal-backed Triathlon PKR system (62%). Demographic parameters, knee range of motion (ROM), tibiofemoral alignment, implant survival (as estimated with the Kaplan–Meier curve), and clinical-functional outcomes (as measured with the Knee Society Score) were analyzed. Results: Average patient age was 65.5 (range, 36–87) years and mean follow-up was 8.2 (range, 2.1–12.8) years. Thirty LUKAs (71.4%) were implanted in women. The main reason for performing a LUKA was osteoarthritis (88.1%). No patient developed post-surgical complications or had to be re-operated. Overall LUKA survival was 100% at 1-year and 5-year's follow-up. Knee Society Score, knee ROM and tibiofemoral alignment all improved significantly post-surgery (p < 0.001). The clinical Knee Society Score increased from 46.5 ± 14.5 pre-surgery to 93.5 ± 10.3 post-surgery, the functional Knee Society Score increased from 48.1 ± 13.5 pre-surgery to 94.6 ± 9.3 post-surgery, maximum flexion increased from 108.5 ± 8.7 degrees pre-surgery to 121 ± 8.9 degrees post-surgery and tibiofemoral alignment was corrected from 13.1 ± 1.74 degrees pre-surgery to 5.7 ± 0.8 degrees post-surgery. There were no statistically significant clinical-functional improvement or knee ROM differences between groups (p < 0.05, respectively). Conclusion: LUKA is a valid and definitive option for patients with lateral tibiofemoral osteoarthritis, with a survival rate of > 95% at 5-years follow-up. Clinical-functional outcomes are the same, irrespective of the tibial component used. [ABSTRACT FROM AUTHOR]